Renal denervation as a high blood pressure treatment is looking less exciting by the day, with the latest bad news coming from Covidien. The Dublin, Ireland–based medical device giant said Tuesday that it will exit its OneShot renal ...
St. Jude Medical, a medical device firm, has announced that its EnligHTN Multi-Electrode Renal Denervation System offers a safe, rapid and sustained reduction in measurements of blood pressure after a year. The company presented the new ...
Tags: EnligHTN Renal, Blood Pressure
US-based medical device company St Jude Medical has commenced its EnligHTNment clinical study. The EnligHTNment study will assess whether the EnligHTN Multi-Electrode Renal Denervation System can minimize the risk of major cardiovascular ...
Tags: St Jude Medical, Clinical Study
St. Jude Medical, a US-based medical device company, has enrolled the first patient for the EnligHTN III trial. During the study, the safety and performance of the second-generation EnligHTN Renal Denervation System in patients with ...
St Jude Medical is planning to begin EnligHTNment study, designed to evaluate whether patients with hypertension treated with its EnligHTN renal denervation system can provide additional benefits beyond a reduction in blood pressure. The ...
Tags: Medical, minimally invasive device, EnligHTN
St Jude Medical has enrolled the first patient in EnligHTN II trial of its multi-electrode renal denervation technology for treating patients with drug-resistant hypertension. The CE-marked EnligHTN renal denervation system, which ...
Tags: EnligHTN II trial, Medical, drug resistant hypertension
St Jude Medical's multi-electrode renal denervation technology was proven to be safe and effective and showed sustained reduction in office and ambulatory blood pressure measurements, at six months post treatment in patients with ...